Agilent Technologies, Inc. (NYSE:A) Shares Sold by Bamco Inc. NY

Bamco Inc. NY lessened its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 4.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 78,663 shares of the medical research company's stock after selling 3,698 shares during the quarter. Bamco Inc. NY's holdings in Agilent Technologies were worth $11,680,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of A. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies in the third quarter worth about $28,000. Crewe Advisors LLC lifted its position in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company's stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Ashton Thomas Securities LLC purchased a new stake in shares of Agilent Technologies during the third quarter valued at approximately $31,000. Ridgewood Investments LLC purchased a new position in shares of Agilent Technologies in the second quarter worth $29,000. Finally, Fortitude Family Office LLC raised its holdings in Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock valued at $35,000 after buying an additional 95 shares during the last quarter.

Insider Buying and Selling

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Agilent Technologies Price Performance

NYSE A traded down $0.62 during trading on Tuesday, hitting $138.96. 506,099 shares of the stock traded hands, compared to its average volume of 1,722,821. The company has a market capitalization of $39.93 billion, a P/E ratio of 31.58, a price-to-earnings-growth ratio of 4.38 and a beta of 1.07. Agilent Technologies, Inc. has a 12-month low of $124.16 and a 12-month high of $155.35. The firm has a 50-day simple moving average of $137.60 and a 200-day simple moving average of $137.15. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be issued a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.71%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.24. Agilent Technologies's dividend payout ratio (DPR) is 21.27%.

Wall Street Analyst Weigh In

Several research firms have recently commented on A. Barclays dropped their target price on shares of Agilent Technologies from $145.00 to $135.00 and set an "underweight" rating for the company in a research report on Wednesday, November 27th. UBS Group boosted their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a "neutral" rating in a report on Thursday, August 22nd. Stifel Nicolaus reiterated a "buy" rating and issued a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Sanford C. Bernstein dropped their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a research note on Tuesday, November 26th. Finally, StockNews.com cut Agilent Technologies from a "buy" rating to a "hold" rating in a research report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of "Hold" and a consensus target price of $143.40.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.